webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N3-D-Dab(Boc)-OH

  CAS No.: 1922891-74-4   Cat No.: BADC-01760 4.5  

N3-D-Dab(Boc)-OH is a D-diaminobutyric acid based azide ADC linker intermediate with Boc protection, facilitating site-specific bioorthogonal conjugation in antibody-drug conjugates for stable payload attachment. Keywords: ADC linker, azide linker, diamino acid, Boc protection, targeted drug delivery.

N3-D-Dab(Boc)-OH

Structure of 1922891-74-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C9H16N4O4
Molecular Weight
244.25

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
(2R)-2-azido-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
Canonical SMILES
CC(C)(C)OC(=O)NCCC(C(=O)O)N=[N+]=[N-]
InChI
InChI=1S/C9H16N4O4/c1-9(2,3)17-8(16)11-5-4-6(7(14)15)12-13-10/h6H,4-5H2,1-3H3,(H,11,16)(H,14,15)/t6-/m1/s1
InChIKey
JLMWKZYQNHSSAD-ZCFIWIBFSA-N

N3-D-Dab(Boc)-OH, a derivative of N3-Dab (3-amino-1,4-diaminobutane) with a Boc (tert-butoxycarbonyl) protecting group, is a crucial building block in the synthesis of peptides, peptide-based therapeutics, and bioactive molecules. The presence of the Boc group allows selective protection of the amino functionality during peptide synthesis, facilitating the controlled addition of amino acids to growing peptide chains. N3-D-Dab(Boc)-OH is essential in the design and development of complex peptides and conjugates, particularly those targeting specific diseases or biological pathways.

One of the primary applications of N3-D-Dab(Boc)-OH is in peptide synthesis, where it serves as an important intermediate for incorporating the D-Dab residue into peptides. D-amino acids, such as D-Dab, are used in peptide synthesis to enhance stability, prevent enzymatic degradation, and alter the conformation of the peptides. The Boc group protects the amino group during synthesis, ensuring efficient peptide elongation without unwanted side reactions. This property makes N3-D-Dab(Boc)-OH a valuable tool in producing stable and biologically active peptides for therapeutic applications, including antimicrobial, anticancer, and hormone-like peptides.

N3-D-Dab(Boc)-OH is also employed in the design of peptide conjugates, where it can be used to attach peptides to various bioactive molecules such as drugs, targeting ligands, or diagnostic agents. The D-Dab unit plays a crucial role in improving the pharmacokinetics and targeting properties of the conjugates. By linking peptides to small molecules or antibodies, researchers can create conjugates with enhanced specificity, reduced toxicity, and improved delivery efficiency. This application is particularly valuable in the development of targeted therapies, such as antibody-drug conjugates (ADCs) or peptide-drug conjugates (PDCs), for cancer or other diseases.

Another significant application of N3-D-Dab(Boc)-OH is in the creation of peptide mimetics. By incorporating the D-Dab unit into small molecule scaffolds or cyclic peptides, researchers can design compounds that mimic the biological activity of natural peptides but with improved pharmacological properties. N3-D-Dab(Boc)-OH is an ideal precursor for these peptide mimetics, which are often used in drug discovery to develop potent inhibitors of protein-protein interactions, enzymes, or receptors. This application extends the versatility of N3-D-Dab(Boc)-OH in pharmaceutical research and development.

In addition, N3-D-Dab(Boc)-OH is employed in the synthesis of functionalized materials, such as bioactive polymers and hydrogels, for drug delivery applications. The D-Dab residue provides a unique functional group that can be used for conjugation or crosslinking, while the Boc group ensures that the amine group is protected during the polymerization process. These functionalized materials are designed for controlled drug release, tissue targeting, and bioresponsive drug delivery, making N3-D-Dab(Boc)-OH an important tool in the development of advanced drug delivery systems and biomedical materials.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: N3-L-Lys(Mtt)-OH | H-L-Tyr(2-azidoethyl)-OH hydrochloride | Me-Tet-PEG2-NHS | Sulfo-SMPB sodium | Nα-Azido-Nε-Fmoc-L-Lysine | EC1167 | (2S)-N3-HABA | m-PEG2-Tos | N-Boc-MeVal | 12-Azido-dodecanoyl-OSu | N3-D-Dab(Boc)-OH
Send Inquiry
Verification code
Inquiry Basket